Abstract
Introduction
Acromegaly is a rare but potentially life-threatening disease, if not promptly managed, for the systemic complications due to the GH/IGF-I hypersecretion. According to the increased population life span, the number of older acromegaly patients is growing. We aim to investigate clinical features of elderly acromegaly (elderly-ACRO) and to identify the risk factors for the occurrence of comorbidities in elderly-ACRO.
Materials and methods
A retrospective and multi-center study was performed on acromegaly patients. Acromegaly comorbidities were compared among elderly-ACRO (>65 years), young acromegaly patients (young-ACRO if ≤65 years) and a control group of age and gender-matched subjects.
Result
Fifty of the 189 enrolled patients were elderly-ACRO (26.5%). Cardiovascular, metabolic, neurological/psychiatric and joint/articular disorders, nodular thyroid disease, sleep apnoea syndrome and skeletal fragility occurred more frequently in elderly-ACRO as compared to controls. Cardiovascular and metabolic disorders, nodular thyroid disease occurred significantly more frequently in elderly-ACRO as compared to young-ACRO and controls. On the other hand, neurological/psychiatric, joint/articular disorders and bone fragility occur with a similar frequency among elderly and young-ACRO. We found that elderly-ACRO had an increased risk for the occurrence of systemic arterial hypertension (p < 0.001, OR: 5.4 95%IC:2.6–10.9), left ventricular hypertrophy (p = 0.01, OR: 3 95%IC: 1.5–5.8) and metabolic disorders (p = 0.006, OR: 4.1 95%IC: 2–8.3).
Conclusion
Our results may suggest that some acromegaly comorbidities may be predominantly due to acromegaly “per-se” rather than to aging. On the contrary, cardiovascular and metabolic disorders seem to be due to aging as well.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
L. Katznelson, E.R. Laws, S. Melmed, M.E. Molitch, M.H. Murad, A. Utz et al. Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(11), 3933–3951 (2014)
A. Colao, L.F.S. Grasso, A. Giustina, S. Melmed, P. Chanson, A.M. Pereira et al. Acromegaly. Nat. Rev. Dis. Prim. 5(1), 20 (2019)
M.R. Ambrosio, I. Gagliardi, S. Chiloiro, A.G. Ferreira, M. Bondanelli, A. Giampietro, A. Bianchi, L. Marinis, M. Fleseriu, M.C. Zatelli, Acromegaly in the elderly patients. Endocrine 68(1), 16–31 (2020). https://doi.org/10.1007/s12020-020-02206-7
A. Colao, R. Pivonello, L. Spinelli, M. Galderisi, R. Auriemma, M. Galdiero et al. A retrospective analysis on bio-chemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients. J. Endocrinol. Invest 30(6), 497–506 (2007)
J.D. Nabarro, Acromegaly. Clin. Endocrinol. 26, 481–512 (1987)
G. Minniti, V. Esposito, M. Piccirilli, A. Fratticci, A. Santoro, M.L. Jaffrain-Rea, Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature. Eur. J. Endocrinol. 153(6), 723–735 (2005)
P.K. Whelton, R.M. Carey, W.S. Aronow, D.E. Casey Jr, K.J. Collins, C. Dennison Himmelfarb, S.M. DePalma, S. Gidding, K.A. Jamerson, D.W. Jones, E.J. MacLaughlin, P. Muntner, B. Ovbiagele, S.C. Smith Jr, C.C. Spencer, R.S. Stafford, S.J. Taler, R.J. Thomas, K.A. Williams Sr, J.D. Williamson, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71(6), e13 (2018)
L.M. Fatti, B. Cangiano, G. Vitale, L. Persani, G. Mantovani, E. Sala, M. Arosio, P. Maffei, F. Dassie, M. Mormando, A. Giampietro, L. Tanda, E.R. Masiello, E. Nazzari, D. Ferone, S. Corbetta, E. Passeri, F. Guaraldi, S. Grottoli, S. Cannavò, M.L.T. Torre, D. Soranna, A. Zambon, F. Cavagnini, M. Scacchi; Study Group on Motor Disability in Acromegaly of the Italian Society of Endocrinology, Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity. Pituitary 22(5), 552–560 (2019). https://doi.org/10.1007/s11102-019-00966-8
A. Giustina, G. Barkhoudarian, A. Beckers, A. Ben-Shlomo, N. Biermasz, B. Biller, et al. Multidisciplinary management of acromegaly: A consensus. Rev. Endocr. Metab. Disord. 2020; https://doi.org/10.1007/s11154-020-09588-z
S. Melmed, M.D. Bronstein, P. Chanson, A. Klibanski, F.F. Casanuela, J.A.H. Wass, C.J. Strasburger, A. Luger, D.R. Clemmons, A. Giustina, A Consensus Statement on acromegaly therapeutic outcomes. Nat. Rev. Endocrinol. 14(9), 552–561 (2018)
A.M. Ramos-Leví, M. Marazuela. Bringing cardiovascular comorbidities in acromegaly to an update. How should we diagnose and manage them? Front. Endocrinol. 10, 120 (2019)
A. Colao, D. Ferone, P. Marzullo, G. Lombardi, Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr. Rev. 25(1), 102–152 (2004)
L. Maione, T. Brue, A. Beckers, B. Delemer, P. Petrossians, F. Borson-Chazot et al. Changes in the management and comorbidities of acromegaly over three decades: the French acromegaly registry. Eur. J. Endocrinol. 176(5), 645–655 (2017)
S. Fieffe, I. Morange, P. Petrossians, P. Chanson, V. Rohmer, C. Cortet et al. Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French acromegaly registry. Eur. J. Endocrinol. 164(6), 877–884 (2011)
A.V. Dreval, I.V. Trigolosova, I.V. Misnikova, Y.A. Kovalyova, R.S. Tishenina, I.A. Barsukov et al. Prevalence of diabetes mellitus in patients with acromegaly. Endocr. Connect. 3(2), 93–98 (2014)
H. Biering, G. Knappe, H. Gerl, H. Lochs, Prevalence of diabetes in acromegaly and Cushing syndrome. Acta Med Austriaca 27(1), 27–31 (2000)
O. Alexopoulou, M. Bex, P. Kamenicky, A.B. Mvoula, P. Chanson, D. Maiter, Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients. Pituitary 17(1), 81–89 (2014)
J.M. Silverstein, E.D. Roe, K.M. Munir, J.L. Fox, B. Emir, M. Kouznetsova et al. Use of electronic health records to characterize a rare disease in the u.s.: treatment, comorbidities, and follow-up trends among patients with a confirmed diagnosis of acromegaly. Endocr. Pract. 24(6), 517–526 (2018)
J. Dal, U. Feldt-Rasmussen, M. Andersen, L. Kristensen, P. Laurberg, L. Pedersen et al. Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur. J. Endocrinol. 175(3), 181–190 (2016)
A.L. Espinosa-de-los-Monteros, B. González, G. Vargas, E. Sosa, M. Mercado, Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism. Pituitary 14(3), 231–235 (2011)
M.R. Gadelha, L. Kasuki, D.S.T. Lim, M. Fleseriu, Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr. Rev. 40(1), 268–332 (2019)
K.M.J.A. Claessen, A.N. Canete, P.W. de Bruin, A.M. Pereira, M. Kloppenburg, H.M. Kroon et al. Acromegalic arthropathy in various stages of the disease: an MRI study. Eur. J. Endocrinol. 176(6), 779–790 (2017)
G. Mazziotti, F. Maffezzoni, S. Frara, A. Giustina, Acromegalic osteopathy. Pituitary 20(1), 63–69 (2017)
B. Cangiano, E. Giusti, C. Premoli, D. Soranna., G. Vitale, S. Grottoli, et al. “PRO-ACRO” study group on Motor Disability in Acromegaly, of the Italian Society of Endocrinology (SIE). Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life. Endocrine. 2022. https://doi.org/10.1007/s12020-022-03106-8
L.L. Kropf, M. Madeira, L. Vieira Neto, M.R. Gadelha, M.L.F. de Farias, Functional evaluation of the joints in acromegalic patients and associated factors. Clin. Rheumatol. 32(7), 991–998 (2013)
N.R. Biermasz, M.J.E. Wassenaar, A.A. van der Klaauw, A.M. Pereira, J.W.A. Smit, F. Roelfsema et al. Pretreatment insulin- like growth factor-I concentrations predict radiographic osteoarthritis in acromegalic patients with long-term cured dis- ease. J. Clin. Endocrinol. Metab. 94(7), 2374–2379 (2009)
I. Gagliardi, S. Chiloiro, M. Vallillo, M. Bondanelli, S. Volpato, A. Giampietro, A. Bianchi, L. De Marinis, M.C. Zatelli, M.R. Ambrosio, Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study. BMC Geriatr. 21(1), 598 (2021). https://doi.org/10.1186/s12877-021-02549-4
A. Giustina, F.F. Casanueva, F. Cavagnini, P. Chanson, D. Clemmons, L.A. Frohman, R. Gaillard, K. Ho, P. Jaqut, D.L. Kleinberg, S.W.J. Lamberts, G. Lombardi, M. Sheppard, C.J. Sreasburger, M.L. Vance, J.A.H. Wass, S. Melmed, Diagnosis and treatment of acromegaly complications. J. Endocrinol. Invest 26, 1242–1247 (2003)
M. Fleseriu, B.M.K. Biller, P.U. Freda, M.R. Gadelha, A. Giustina, L. Katznelson, M.E. Molitch, S.L. Samson, C.J. Strasburger, A.J. van der Lely, S. Melmed, A Pituitary Society update to acromegaly management guidelines. Pituitary 24(1), 1–13 (2021). https://doi.org/10.1007/s11102-020-01091-7.
P. Petrossians, A.F. Daly, E. Natchev, L. Maione, K. Blijdorp, M. Sahnoun-Fathallah et al. Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) database. Endocr. Relat. Cancer 24(10), 505–518 (2017)
A. Ribeiro-Oliveira, M.M. Abrantes, A.L. Barkan, Complex rhythmicity and age dependence of growth hormone secretion are preserved in patients with acromegaly: further evidence for a present hypothalamic control of pituitary somatotropinomas. J. Clin. Endocrinol. Metab. 98(7), 2959–2966 (2013)
D. Cuevas-Ramos, J.D. Carmichael, O. Cooper, V.S. Bonert, A. Gertych, A.N. Mamelak et al. A structural and functional acromegaly classification. J. Clin. Endocrinol. Metab. 100(1), 122–131 (2015)
S. Chiloiro, A. Bianchi, A. Giampietro, L. De Marinis (2019) Somatotropic Axis in Human Aging. In: Ilpo Huhtaniemi and Luciano Martini, (Eds.), Encyclopedia of Endocrine Diseases, Second Edition, vol. 1, pp. 700–707. Oxford: Academic Press. https://doi.org/10.1016/B978-0-12-812199-3.66167-4
A.M. Arafat, M. Möhlig, M.O. Weickert, F.H. Perschel, J. Purschwitz, J. Spranger et al. Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J. Clin. Endocrinol. Metab. 93(4), 1254–1262 (2008)
E.C. degli Uberti, M.R. Ambrosio, S.G. Cella, A.R. Margutti, G. Trasforini, A.E. Rigamonti et al. Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man. J. Clin. Endocrinol. Metab. 82(9), 2885–2888 (1997)
D. Cuevas-Ramos, J.D. Carmichael, O. Cooper, V.S. Bonert, A. Gertych, A.N. Mamelak et al. A structural and functional acromegaly classification. J. Clin. Endocrinol. Metab. 100(1), 122–131 (2015)
K. Tanimoto, N. Hizuka, I. Fukuda, K. Takano, T. Hanafusa, The influence of age on the GH–IGF1 axis in patients with acromegaly. Eur. J. Endocrinol. 159(4), 375–379 (2008)
S. Petersenn, M. Buchfelder, B. Gerbert, H. Franz, H.J. Quabbe, H.M. Schulte et al. Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German acromegaly register. Clin. Endocrinol. 71(3), 400–405 (2009)
S. Chiloiro, A. Bianchi, F. Doglietto, C. de Waure, A. Giampietro, A. Fusco, D. Iacovazzo, L. Tartaglione, F. Di Nardo, F. Signorelli, L. Lauriola, C. Anile, G. Rindi, G. Maira, A. Pontecorvi, De, L. Marinis, Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review. Pituitary 17(3), 267–276 (2014). https://doi.org/10.1007/s11102-013-0500-6.23
M. Arosio, G. Reimondo, E. Malchiodi, P. Berchialla, A. Borraccino, L. De Marinis et al. Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur. J. Endocrinol. 167(2), 189–198 (2021)
M.J.A. Puchner, U.J. Knappe, D.K. Lüdecke, Pituitary surgery in elderly patients with acromegaly. Neurosurgery 36(4), 677–684 (1995)
K. Arita, H. Hirano, S. Yunoue, S. Fujio, A. Tominaga, T. Sakoguchi et al. Treatment of elderly acromegalics. Endocr. J. 55(5), 895–903 (2008)
H. Sun, J. Brzana, C.G. Yedinak, S.H. Gultekin, J.B. Delashaw, M. Fleseriu, Factors associated with biochemical remission after microscopic transsphenoidal surgery for acromegaly. J. Neurol. Surg. Part B Skull Base 75(1), 47–52 (2014)
M. Taghvaei, S.M. Sadrehosseini, J. Ardakani, M. Nakhjavani, M. Zeinalizadeh, Endoscopic endonasal approach to the growth hormone-secreting pituitary adenomas: endocrinologic outcome in 68 patients. World Neurosurg. 11, e259–e268 (2018)
A. Spina, M. Losa, P. Mortini, Pituitary adenomas in elderly patients: clinical and surgical outcome analysis in a large series. Endocrine 65(3), 637–645 (2019)
Y. Sasagawa, Y. Hayashi, O. Tachibana, A. Nakagawa, M. Oishi, T. Takamura et al. Transsphenoidal surgery for elderly patients with acromegaly and its outcomes: comparison with younger patients. World Neurosurg. 118, e229–e234 (2018)
S. Chiloiro, A. Giampietro, F. Mirra, F. Donfrancesco, T. Tartaglione, P.P. Mattogno, F. Angelini, L. Liverana, M. Gessi, A. Carmelo, G. Rindi, A. Giustina, M. Fleseriu, A. Pontecorvi, L. De Marinis, A. Bianchi, Pegvisomant and Pasireotide LAR as second-line therapy in acromegaly: clinical effectiveness and predictors of response. Eur. J. Endocrinol. 184(2), 217–229 (2021). https://doi.org/10.1530/EJE-20-0767
S. Chiloiro, A. Giampietro, A. Bianchi, T. Tartaglione, C. Bima, M.G. Vita et al. Acromegaly can be cured by first-line pasireotide treatment? Endocrine 64(1), 196–199 (2019)
S. Chiloiro, C. Bima, T. Tartaglione, A. Giampietro, M. Gessi, L. Lauretti, et al. Pasireotide and pegvisomant combination treatment in acromegaly resistant to second-line therapies: a longitudinal study. J. Clin. Endocrinol. Metab. 2019. https://doi.org/10.1210/jc.2019-00825
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethics
All procedures performed in the study were in accordance with the ethical standards of the institutional review board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by Institutional Review Board of the Gemelli Hospital, Catholic University of the Sacred Heart, Rome, and of Azienda Ospedaliera Universitaria of Ferrara.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chiloiro, S., Giampietro, A., Gagliardi, I. et al. Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients?. Endocrine 80, 142–151 (2023). https://doi.org/10.1007/s12020-022-03261-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-022-03261-y